INTRODUCTIONRecent survey-based studies have investigated various factors influencing medical students' career choices, including academic status, socioeconomic factors, and mentorship.1,2 Perceived barriers to career advancement faced by resident physicians in comparison…
Read More
INTRODUCTIONBenign Familial Pemphigus, or Hailey-Hailey Disease (HHD), affects intertriginous areas of the skin causing epidermal blistering and vesicles that coalesce into weeping and crusting plaques.1 The loss-of-function mutation of the…
Read More
INTRODUCTIONHidradenitis suppurativa (HS) is a chronic, inflammatory skin disease characterized by recurrent nodules and abscesses that may rupture, leading to the formation of sinus tracts and scarring.1 Lesions most frequently…
Read More
INTRODUCTIONNew cancer cases in 2020 in Europe, excluding non-melanoma skin cancer, are estimated at 4 million cases.1 Breast (530,000 patients), colorectal (520,000), lung (480,000), and prostate (470,000) cancer accounted for…
Read More
INTRODUCTIONKeratosis pilaris (KP) is characterized by hyperkeratotic folliculocentric papules distributed on the arms, upper legs, and buttocks.1 It commonly occurs with perifollicular erythema. The papules and erythema are benign but…
Read More
INTRODUCTIONEczema affects approximately 31 million people in the United States and is characterized by dryness, itchiness, scaling, roughness, irritation, or discoloration as well as periodic unpredictable flares.1 Developing a good…
Read More
INTRODUCTIONThe underlying cause of Alzheimer's disease (AD), a progressive neurologic disorder that is the most common cause of dementia, is poorly understood. At present, the treatments currently available have limited…
Read More
INTRODUCTIONAcne vulgaris is a common inflammatory cutaneous disorder of the pilosebaceous unit of the skin (comprising the hair follicle, hair shaft, and sebaceous gland), leading to the development of whiteheads,…
Read More
In this supplement:Efficacy of Over-The-Counter Cream in Reducing Eczema SignsEczema affects approximately 31 million people in the United States and is characterized by dryness, itchiness, scaling, roughness, irritation, or discoloration…
Read More
In this supplement: Brodalumab is an Efficacious, Safe, and Cost-Effective IL-17 Receptor Blocker for the Treatment of Moderate-to-Severe Plaque Psoriasis: 2023 UpdatePsoriasis remains a highly prevalent condition in the United…
Read More
INTRODUCTIONEczema, also called atopic dermatitis, is an inflammatory skin disease characterized by skin barrier damage, which translates to itch, dry skin, rash, scaling, blisters, and skin their eczema flares, patients…
Read More
INTRODUCTIONEczema, or atopic dermatitis (AD), is a common skin condition which is estimated to affect >31 million people in United States, with up to 25% of children and almost 10%…
Read More
